GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Autodesk, Inc. (ADSK) [hlAlert]

Rating:
Buy ADSK
up 10.05 %

Autodesk, Inc. (ADSK) rated Buy with price target $60 by Canaccord Genuity

Posted on: Wednesday,  Sep 30, 2015  8:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Buy Autodesk, Inc. (NASDAQ: ADSK) on 09/30/2015, when the stock price was $45.43. Since
then, Autodesk, Inc. has gained 10.06% as of 11/20/2015's recent price of $50.00.
If you would have followed this Canaccord Genuity's recommendation on ADSK, you would have gained 10.05% of your investment in 51 days.

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson?s disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/30/2015 8:25 AM Buy
None
45.43 60.00
as of 12/13/2013
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/20/2015 9:25 AM Buy
None
57.36 70.00
2/27/2015 11:25 AM Buy
None
64.89 73.00
11/21/2014 9:25 AM Buy
None
61.18 70.00
5/14/2014 12:00 AM Buy
None
60.00
2/27/2014 9:25 AM Hold
None
54.28 52.00
1/17/2014 3:25 PM Hold
None
53.16 50.00
9/27/2013 11:25 AM Hold
None
41.83 42.00
8/24/2012 9:25 AM Hold
None
28.03 32.00
8/19/2011 9:25 AM Buy
None
26.61 42.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy